Chapter  1  Biology of standard necrosis markers: troponins, creatine kinase, and myoglobin
Chapter  2  The evolution and revolution of necrosis markers in modern cardiology
Chapter  3  Troponins: analytical issues
Chapter  4  Utility of troponin testing for risk stratification and treatment decision making in acute coronary syndromes
Chapter  5  Use of cardiac troponins in ST-segment elevation myocardial infarction
Chapter  6  Necrosis marker testing in renal failure
Chapter  7  Necrosis marker testing in heart failure
Chapter  8  Necrosis markers in conditions other than acute coronary syndromes and heart failure
Chapter  9  Measurement of necrosis markers following PCI and CABG
Chapter  10  Emerging biomarkers in Acute Coronary Syndrome
Chapter  11  Ischemia markers: the search for the holy grail in ACS
Chapter  12  Inflammation and inflammatory markers in cardiovascular disease: From Bench to Bedside
Chapter  13  Inflammation in the Development and Complications of Coronary Artery Disease
Chapter  14  Role of inflammatory marker testing in ACS
Chapter  15  Role of inflammatory markers in heart failure
Chapter  16  Biology of the natriuretic peptides
Chapter  17  Natriuretic peptides and structural heart disease: cardiac correlates of natriuretic peptide elevation
Chapter  18  Natriuretic peptide testing: laboratory considerations
Chapter  19  Population testing with natriuretic peptides: Potential promises and pitfalls
Chapter  20  Application of natriuretic peptides for use in primary care
Chapter  21  Natriuretic Peptide Testing for Diagnostic Evaluation of Patients with Suspected Acute Heart Failure
Chapter  22  Natriuretic peptide testing for patients with acute and chronic coronary disease
Chapter  23  Natriuretic peptides and prognostication: Predicting outcomes across the spectrum of medical conditions
Chapter  24  Natriuretic peptides for guidance of acute and chronic heart failure therapy
Chapter  25  Natriuretic peptide testing in patients with renal disease
Chapter  26  Emerging biomarkers of cardiac failure
Chapter  27  Rationale for clinical measurement of markers of thrombosis
Chapter  28  Markers of platelet function and assessment of platelet activation and aggregation
Chapter  29  Contemporary interpretation of guidelines for lipids in modern medicine
Chapter  30  Biomarkers in the metabolic syndrome
Chapter  31  Emerging lipid-based biomarkers
Chapter  32  Genetic markers: future promise in cardiovascular medicine
Chapter  33  Metabolic and proteomic markers in cardiovascular medicine